195 related articles for article (PubMed ID: 18826606)
1. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.
Wong V; Wang DY; Warren K; Kulkarni S; Boerner S; Done SJ; Leong WL
BMC Cancer; 2008 Sep; 8():277. PubMed ID: 18826606
[TBL] [Abstract][Full Text] [Related]
2. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
Symmans WF; Ayers M; Clark EA; Stec J; Hess KR; Sneige N; Buchholz TA; Krishnamurthy S; Ibrahim NK; Buzdar AU; Theriault RL; Rosales MF; Thomas ES; Gwyn KM; Green MC; Syed AR; Hortobagyi GN; Pusztai L
Cancer; 2003 Jun; 97(12):2960-71. PubMed ID: 12784330
[TBL] [Abstract][Full Text] [Related]
3. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
4. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
Lyng MB; Laenkholm AV; Pallisgaard N; Vach W; Knoop A; Bak M; Ditzel HJ
Cell Oncol; 2007; 29(5):361-72. PubMed ID: 17726259
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.
Ellis M; Davis N; Coop A; Liu M; Schumaker L; Lee RY; Srikanchana R; Russell CG; Singh B; Miller WR; Stearns V; Pennanen M; Tsangaris T; Gallagher A; Liu A; Zwart A; Hayes DF; Lippman ME; Wang Y; Clarke R
Clin Cancer Res; 2002 May; 8(5):1155-66. PubMed ID: 12006532
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
7. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.
Mattie MD; Benz CC; Bowers J; Sensinger K; Wong L; Scott GK; Fedele V; Ginzinger D; Getts R; Haqq C
Mol Cancer; 2006 Jun; 5():24. PubMed ID: 16784538
[TBL] [Abstract][Full Text] [Related]
8. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer.
Sotiriou C; Powles TJ; Dowsett M; Jazaeri AA; Feldman AL; Assersohn L; Gadisetti C; Libutti SK; Liu ET
Breast Cancer Res; 2002; 4(3):R3. PubMed ID: 12052255
[TBL] [Abstract][Full Text] [Related]
10. The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology.
Rapkiewicz A; Espina V; Zujewski JA; Lebowitz PF; Filie A; Wulfkuhle J; Camphausen K; Petricoin EF; Liotta LA; Abati A
Cancer; 2007 Jun; 111(3):173-84. PubMed ID: 17487852
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.
Taylor KJ; Sims AH; Liang L; Faratian D; Muir M; Walker G; Kuske B; Dixon JM; Cameron DA; Harrison DJ; Langdon SP
Breast Cancer Res; 2010; 12(3):R39. PubMed ID: 20569502
[TBL] [Abstract][Full Text] [Related]
12. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.
André F; Michiels S; Dessen P; Scott V; Suciu V; Uzan C; Lazar V; Lacroix L; Vassal G; Spielmann M; Vielh P; Delaloge S
Lancet Oncol; 2009 Apr; 10(4):381-90. PubMed ID: 19249242
[TBL] [Abstract][Full Text] [Related]
13. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.
Barry WT; Kernagis DN; Dressman HK; Griffis RJ; Hunter JD; Olson JA; Marks JR; Ginsburg GS; Marcom PK; Nevins JR; Geradts J; Datto MB
J Clin Oncol; 2010 May; 28(13):2198-206. PubMed ID: 20368555
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer.
Foukakis T; Lövrot J; Sandqvist P; Xie H; Lindström LS; Giorgetti C; Jacobsson H; Hedayati E; Bergh J
Mol Oncol; 2015 Aug; 9(7):1384-91. PubMed ID: 25888067
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Pusztai L; Ayers M; Stec J; Clark E; Hess K; Stivers D; Damokosh A; Sneige N; Buchholz TA; Esteva FJ; Arun B; Cristofanilli M; Booser D; Rosales M; Valero V; Adams C; Hortobagyi GN; Symmans WF
Clin Cancer Res; 2003 Jul; 9(7):2406-15. PubMed ID: 12855612
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.
Laurell H; Bouisson M; Berthelemy P; Rochaix P; Dejean S; Besse P; Susini C; Pradayrol L; Vaysse N; Buscail L
World J Gastroenterol; 2006 Jun; 12(21):3344-51. PubMed ID: 16733850
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR.
O'Driscoll L; Kenny E; Mehta JP; Doolan P; Joyce H; Gammell P; Hill A; O'Daly B; O'Gorman D; Clynes M
Cancer Genomics Proteomics; 2008; 5(2):94-104. PubMed ID: 18460738
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.
Assersohn L; Gangi L; Zhao Y; Dowsett M; Simon R; Powles TJ; Liu ET
Clin Cancer Res; 2002 Mar; 8(3):794-801. PubMed ID: 11895911
[TBL] [Abstract][Full Text] [Related]
20. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling.
Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I
BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
